Mylan NVs EpiPen Product Illustrations As Company's Move to Curb EpiPen Costs Blasted as PR Fix by Congress

Mylan NV's EpiPen allergy shots sit on display for a photograph in Princeton, Illinois, U.S., on Friday, Aug. 26, 2016. In response to intense criticism over the past few days, Mylan NV moved Thursday to expand assistance programs that help patients with high out-of-pocket expenses -- but didn't go as far as cutting the treatment's list price. Health insurers and U.S. lawmakers criticized the effort as an attempt to cover a 400 percent price hike that won't make the drug more affordable. Photographer: Daniel Acker/Bloomberg via Getty Images
Mylan NV's EpiPen allergy shots sit on display for a photograph in Princeton, Illinois, U.S., on Friday, Aug. 26, 2016. In response to intense criticism over the past few days, Mylan NV moved Thursday to expand assistance programs that help patients with high out-of-pocket expenses -- but didn't go as far as cutting the treatment's list price. Health insurers and U.S. lawmakers criticized the effort as an attempt to cover a 400 percent price hike that won't make the drug more affordable. Photographer: Daniel Acker/Bloomberg via Getty Images
Mylan NVs EpiPen Product Illustrations As Company's Move to Curb EpiPen Costs Blasted as PR Fix by Congress
COMPRAR LICENCIA
¿Cómo puedo usar esta imagen?
AR$ 208.500,00
ARS
Getty ImagesMylan NVs EpiPen Product Illustrations As Company's Move to Curb..., Fotografía de noticiasMylan NVs EpiPen Product Illustrations As Company's Move to Curb..., Fotografía de noticiasMylan NVs EpiPen Product Illustrations As Company's Move to Curb... Consigue fotografías de noticias de alta resolución y gran calidad en Getty ImagesProduct #:595921818
AR$329.200AR$88.100
Getty Images
In stock

DETALLES

Restricciones:
Póngase en contacto con su oficina local para conocer todos los usos con fines comerciales o promocionales.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
Editorial n.º:
595921818
Colección:
Bloomberg
Fecha de creación:
26 de agosto de 2016
Fecha de subida:
Tipo de licencia:
Con derechos gestionados
Inf. de autorización:
No se cuenta con autorizaciones. Más información
Fuente:
Bloomberg
Nombre del objeto:
MYLAN EPIPEN
Tamaño máx. archivo:
4000 x 2667 px (33,87 x 22,58 cm) - 300 dpi - 3 MB